We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Medical News & Perspectives |

Promising Marker Found for Deadly Prostate Cancer

Bridget M. Kuehn
JAMA. 2009;301(10):1008. doi:10.1001/jama.2009.299.
Text Size: A A A
Published online


A multi-institutional team of scientists has identified a biological marker of prostate cancer progression that may be useful for urine-based screening. The discovery also suggests potential new targets for treatment.

Using a combination of liquid and gas chromatography along with mass spectrometry, the scientists examined levels of various metabolites in 262 samples. These included 42 tissue samples and 110 matched specimens of plasma and urine from 59 patients who had a biopsy positive for prostate cancer, as well as 51 controls (Sreekumar A et al. Nature. 2009;457[7231]:910-914). Based on these results and findings from previous studies suggesting that amino acid metabolism and methylation are enhanced during cancer progression, the researchers identified sarcosine as a promising metabolite. Further interrogations revealed that levels of sarcosine, a product of the methylation of the amino acid glycine, increase as prostate cancer progresses.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles

Users' Guides to the Medical Literature
From Evidence to Recommendations

Users' Guides to the Medical Literature
Overall Confidence in Effect Estimates